PTEN and cancer: PTEN can bind and dephosphorylate Abi1at Y213 and S216, triggering its degradation through the calpain pathway, thereby promoting epithelial differentiation and polarization [99], as well as epithelial–mesenchymal transition and cancer-stem-cell activity [124].